Acetazolamide and Levocarnitine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetazolamide (acetazolamide) and Levocarnitine (levocarnitine). Common drug interactions include nausea among females and haematuria among males.

The phase IV clinical study analyzes what interactions people have when they take Acetazolamide and Levocarnitine. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.



On Jul, 14, 2026

19 people who take Acetazolamide and Levocarnitine together, and have interactions are studied.

Acetazolamide and Levocarnitine drug interactions.

What are the common drug interactions of Acetazolamide and Levocarnitine, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Hypersomnia (excessive daytime sleepiness (eds))
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Constipation
  5. Face oedema (swelling of face)
  6. Insomnia (sleeplessness)
  7. Lymphadenopathy (disease or enlargement of lymph nodes)
  8. Viral infection
  9. Weight decreased
  10. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

male:

  1. Haematuria (presence of blood in urine)
  2. International normalised ratio increased
  3. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  4. Lower respiratory tract infection
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  7. Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Migraine (headache)
  10. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)

What are the common drug interactions of Acetazolamide and Levocarnitine, by age (0-1 to 60+)? *:

0-1:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Hepatomegaly (abnormal enlargement of the liver)

2-9:

n/a

10-19:

  1. Weight decreased
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Abdominal discomfort
  4. Ammonia increased
  5. Carbon dioxide increased
  6. Diarrhoea
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Oedema peripheral (superficial swelling)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Malaise (a feeling of general discomfort or uneasiness)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Haematuria (presence of blood in urine)
  2. International normalised ratio increased

What are the existing conditions these people have? *

  1. Constipation: 4 people, 21.05%
  2. Pain: 4 people, 21.05%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 21.05%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 21.05%
  5. Hypersensitivity: 3 people, 15.79%
  6. Itching: 3 people, 15.79%
  7. Seasonal Allergy (allergic condition due to certain season): 2 people, 10.53%
  8. Nausea And Vomiting: 2 people, 10.53%
  9. Nausea (feeling of having an urge to vomit): 2 people, 10.53%
  10. Depression: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and Levocarnitine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acetazolamide and Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetazolamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levocarnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide and levocarnitine (the active ingredients of Acetazolamide and Levocarnitine, respectively), and Acetazolamide and Levocarnitine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: